Acadia Pharmaceuticals, a San Diego-based biotech developing drugs to treat central nervous system disorders, won a grant Jan. 7 from the Michael J. Fox Foundation.
The grant, valued as high as $830,000, will go toward developing a drug for the treatment of Parkinson’s disease.
, Heather Chambers
